|
|
|
|
|
|
|
|
Home
Call for NominationsBackgroundThe role of the pCODR Expert Review Committee (pERC) is to assess the clinical evidence and cost-effectiveness of cancer drugs in order to make recommendations to the provinces and territories to help guide their drug funding decisions.Composed of up to 16 members, pERC makes recommendations and provides advice to the Ministries of Health and cancer agencies. Patient MemberpERC is looking for a Patient Member who has first-hand experience with the treatment and care of cancer or is the family member of a cancer patient and has developed a deep understanding of the treatment and care of cancer.Desired QualificationsThe successful candidate will have personal knowledge of, experience with, and understanding of issues related to cancer and its management (diagnosis, treatment, and care). They will also have a demonstrated understanding and appreciation of patient needs and priorities and an overall understanding of other patient issues and health care concerns that may impact cancer patient communities.Successful candidates should also possess the following:
All applicants will receive confirmation of receipt of their applications. While we thank all applicants for their submissions, only those under further consideration will be contacted personally. All applications must be received by July 31, 2015. For more information and how to apply, please visit www.hrassociates.ca/cadth-pcodr. To request communication in an accessible format, please contact us at 416.237.1500 (1-866-598-1500) ext.231 or email at pcodr@hrassociates.ca. | ||
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.